Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...

A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ...

The microbiome shapes development of insulin-producing cells in infancy, leading to long-term changes in metabolism and diabetes risk, new research in mice has found.

The results could ultimately help doctors reduce the risk of type 1 diabetes—or potentially even restore lost metabolic function in adulthood—by providing gut microbes that help the pancreas grow and ...

The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer ...

Scientists at Memorial Sloan Kettering Cancer Center have developed personalized mRNA vaccines for pancreatic cancer, with ...

The microbiome shapes the development of insulin-producing cells in infancy, leading to long-term changes in metabolism and ...

Early-life gut microbes could play a key role in protecting against diabetes. A healthy start for a healthier future.

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors ...

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of ...

The team’s findings open a new avenue to better understand the interplay between gut microbes and the pancreas, said Boston College Assistant Professor of Biology Emrah Altindis, a co-author of the ...

Stand Up for Science, a volunteer movement dedicated to defending the contributions of science to the public good and social ...